Drug-Induced Gastroparesis and GLP-1 Drugs A significant number of recent gastroparesis cases have occurred in patients using GLP-1 drugs , particularly: These medications intentionally slow gastric emptying but in some patients, this effect becomes excessive and pathological , leading to stomach paralysis
Third, human studies are highly specific to population, protocol, endpoint, duration, and monitoring design
Researchers found that the participants taking the weight-loss medications had twice the risk of developing neovascular age-related macular degeneration (nAMD) compared to the people not taking them
DR: Writing review & editing
The clinical protocols align with the Endocrine Society's 2024 Obesity Pharmacotherapy Guideline and the AACE Comprehensive Type 2 Diabetes Management Algorithm 2024, per the brand's published medical review policy
How do I know if compounded medication is right for me